Market Research Reports

mHealth Monitoring And Diagnostic Medical Devices Market (Focus On Medical Devices With In-Built Plug-Ins For Connectivity With Devices Like Smartphones And Tablets) Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

111pages
Published Date: 2014-04-28
 

Description


mHealth is an abbreviation for mobile health, a term used for the practice of medicine and public health supported by mobile devices. The term is most commonly used in reference to using mobile communication devices such as mobile phones, tablets, computers and PDAs for health services and information. This report studies the current scenario as well as the future market potential for mHealth monitoring and diagnostic devices (focus on medical devices with in-built plug-ins for connectivity with devices like smartphones and tablets) globally. The mHealth monitoring and diagnostic devices market has been segmented into seven major product types, namely, glucose monitors, blood pressure monitors, pulse oximeters, cardiac monitors, sleep apnea monitors, multi-parameter monitoring devices and others (fetal monitors, neurological monitors) devices.

The market for these devices has been extensively analyzed on the basis of factors such as healthcare and monitoring applications, geographic presence and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The mHealth monitoring and diagnostic devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.

Geographically, the mHealth monitoring and diagnostic devices market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the mHealth monitoring and diagnostic devices market report comprises a qualitative analysis of the overall market considering the factors determining market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status.

The mHealth monitoring and diagnostic devices market report also provides a highlight of the competitive landscape of the market, wherein the heat map analysis of the leading players in the market in terms of products offered by the companies has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the mHealth monitoring and diagnostic devices market such as AT&T, Inc., Bayer HealthCare AG, BioTelemetry, Inc. (CardioNet, Inc.), Boston Scientific Corporation, DexCom, Inc., Dräger AG, F. Hoffmann La-Roche Ltd., Johnson & Johnson, LifeWatch AG, Masimo Corporation, Medtronic, Inc. and Omron Healthcare. Market players are profiled on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The global mHealth monitoring and diagnostic medical devices market is segmented as follows:
  • mHealth Monitoring and Diagnostic Medical Devices Market, by Product Type,
    • Glucose Monitors
    • Blood Pressure Monitors
    • Cardiac Monitors
    • Pulse Oximeters
    • Sleep Apnea Monitors
    • Multi-parameter Monitors
    • Others
  • mHealth Monitoring and Diagnostic Medical Devices Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Table of Contents


Table of Content

Chapter 1 Preface 
1.1 Report Description 
1.2 Market Segmentation 
1.3 Research Methodology 
      1.3.1 Sources 
               1.3.1.1 Secondary Research 
               1.3.1.2 Primary Research 
      1.3.2 Assumptions

Chapter 2 Executive Summary 
2.1 Market Snapshot: Global mHealth Monitoring and Diagnostic Medical Devices Market (2012 & 2019) 
2.2 Global mHealth Monitoring and Diagnostic Medical Devices Market, by Product Type, 2012 (USD Million) 
2.3 Comparative Analysis: Global mHealth Monitoring and Diagnostic Medical Devices Market, By Geography, 2012 & 2019 (Value %)

Chapter 3 Market Overview 
3.1 Overview 
3.2 Market Drivers 
      3.2.1 Increasing penetration of smartphones 
      3.2.2 Ubiquitous mobile access 
      3.2.3 Increase in 3G and 4G networks 
      3.2.4 Increasing incidences of chronic diseases and aging population 
3.3 Market Restraints 
      3.3.1 mHealth market still in its nascent stage and not widely accepted 
      3.3.2 Uncertainty about regulations and standards 
      3.3.3 Lack of legal guidelines on privacy and reimbursement challenges 
3.4 Market Opportunities 
      3.4.1 Government initiatives 
3.5 Porter’s Five Force Analysis: Global mHealth Monitoring and Diagnostic Medical Devices Market 
      3.5.1 Bargaining power of suppliers 
      3.5.2 Bargaining power of buyers 
      3.5.3 Threat of substitutes 
      3.5.4 Threat of new entrants 
      3.5.5 Competitive rivalry 
3.6 Market Attractiveness Analysis: Global mHealth Monitoring and Diagnostic Medical Devices Market, by Geography, 2012

Chapter 4 Global mHealth Monitoring and Diagnostic Medical Devices Market, by Product Type 
4.1 Overview 
      4.1.1 Global mHealth Diagnostic and Medical Devices Market Revenue, by Product Type, 2013 – 2019 (USD Million) 
4.2 Glucose Monitors 
      4.2.1 Global Glucose Monitors Market, 2011 – 2019 (USD Million) 
4.3 Blood Pressure Monitors 
      4.3.1 Global Blood Pressure Monitors Market, 2011 – 2019 (USD Million) 
4.4 Pulse Oximeters 
      4.4.1 Global Pulse Oximeters Market, 2011 – 2019 (USD Million) 
4.5 Cardiac Monitors 
      4.5.1 Global Cardiac Monitors Market, 2011 – 2019 (USD Million) 
4.6 Sleep Apnea Monitors 
      4.6.1 Global Sleep Apnea Monitors Market, 2011 – 2019 (USD Million) 
4.7 Multi-parameter Monitors (Wearable Devices) 
      4.7.1 Global Multi-parameter Monitors (Wearable Devices) Market, 2011 – 2019 (USD Million) 
4.8 Others 
      4.8.1 Global Other Monitors Market, 2011 – 2019 (USD Million)

Chapter 5 Global mHealth Monitoring and Diagnostic Medical Devices Market, by Geography 
5.1 Overview 
      5.1.1 Global mHealth Monitoring and Diagnostic Medical Devices Market Revenue, by Geography, 2011 - 2019 (USD Million) 
5.2 North America 
      5.2.1 North America mHealth Monitoring and Diagnostic Medical Devices Market Revenue, 2011 - 2019 (USD Million) 
5.3 Europe 
      5.3.1 Europe mHealth Monitoring and Diagnostic Medical Devices Market Revenue, 2011 - 2019 (USD Million) 
5.4 Asia-Pacific 
      5.4.1 Asia-Pacific mHealth Monitoring and Diagnostic Medical Devices Market Revenue, 2011 - 2019 (USD Million) 
5.5 Rest of the World (RoW) 
      5.5.1 RoW mHealth Monitoring and Diagnostic Medical Devices Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape 
6.1 Heat Map Analysis for Key Market Players of the mHealth Monitoring and Diagnostic Medical Devices Market

Chapter 7 Recommendations 
7.1 Focus on developing technologically advanced and compatible mobile devices and applications 
7.2 Focus on developing promotional campaigns and public awareness 
7.3 Collaborations and acquisition of start-up organizations 
7.4 Focus on emerging markets of Asia-Pacific and Latin America

Chapter 8 Company Profiles 
8.1 Bayer HealthCare AG 
      8.1.1 Company Overview 
      8.1.2 Financial Overview 
      8.1.3 Product Portfolio 
      8.1.4 Business Strategies 
      8.1.5 Recent Developments 
8.2 BioTelemetry, Inc. (CardioNet, Inc.) 
      8.2.1 Company Overview 
      8.2.2 Financial Overview 
      8.2.3 Product Portfolio 
      8.2.4 Business Strategies 
      8.2.5 Recent Developments 
8.3 Boston Scientific Corporation 
      8.3.1 Company Overview 
      8.3.2 Financial Overview 
      8.3.3 Product Portfolio 
      8.3.4 Business Strategies 
      8.3.5 Recent Developments 
8.4 DexCom, Inc. 
      8.4.1 Company Overview 
      8.4.2 Financial Overview 
      8.4.3 Product Portfolio 
      8.4.4 Business Strategies 
      8.4.5 Recent Developments 
8.5 Dräger AG 
      8.5.1 Company Overview 
      8.5.2 Financial Overview 
      8.5.3 Product Portfolio 
      8.5.4 Business Strategies 
      8.5.5 Recent Developments 
8.6 F. Hoffmann-La Roche Ltd. 
      8.6.1 Company Overview 
      8.6.2 Financial Overview 
      8.6.3 Product Portfolio 
      8.6.4 Business Strategies 
      8.6.5 Recent Developments 
8.7 FitBit, Inc. 
      8.7.1 Company Overview 
      8.7.2 Financial Overview 
      8.7.3 Product Portfolio 
      8.7.4 Business Strategies 
      8.7.5 Recent Developments 
8.8 Fora Care Inc. 
      8.8.1 Company Overview 
      8.8.2 Financial Overview 
      8.8.3 Product Portfolio 
      8.8.4 Business Strategies 
      8.8.5 Recent Developments 
8.9 iHealth Labs, Inc. 
      8.9.1 Company Overview 
      8.9.2 Financial Overview 
      8.9.3 Product Portfolio 
      8.9.4 Business Strategies 
      8.9.5 Recent Developments 
8.10 Johnson & Johnson 
      8.10.1 Company Overview 
      8.10.2 Financial Overview 
      8.10.3 Product Portfolio 
      8.10.4 Business Strategies 
      8.10.5 Recent Developments 
8.11 LifeWatch AG 
      8.11.1 Company Overview 
      8.11.2 Financial Overview 
      8.11.3 Product Portfolio 
      8.11.4 Business Strategies 
      8.11.5 Recent Developments 
8.12 Masimo Corporation 
      8.12.1 Company Overview 
      8.12.2 Financial Overview 
      8.12.3 Product Portfolio 
      8.12.4 Business Strategies 
      8.12.5 Recent Developments 
8.13 Medisana AG 
      8.13.1 Company Overview: 
      8.13.2 Financial Overview 
      8.13.3 Product Portfolio 
      8.13.4 Business Strategies 
      8.13.5 Recent Developments 
8.14 Medtronic, Inc. 
      8.14.1 Company Overview 
      8.14.2 Financial Overview 
      8.14.3 Product Portfolio 
      8.14.4 Business Strategies 
      8.14.5 Recent Developments 
8.15 Nonin Medical, Inc. 
      8.15.1 Company Overview 
      8.15.2 Financial Overview 
      8.15.3 Product Portfolio 
      8.15.4 Business Strategies 
      8.15.5 Recent Developments 
8.16 Omron Healthcare, Inc. 
      8.16.1 Business Overview 
      8.16.2 Financial Overview 
      8.16.3 Product Portfolio 
      8.16.4 Business Strategies 
      8.16.5 Recent Developments 
8.17 Withings, Inc. 
      8.17.1 Company Overview 
      8.17.2 Financial Overview 
      8.17.3 Product Portfolio 
      8.17.4 Business Strategies 
      8.17.5 Recent Developments

List of Figures

 

FIG. 1 mHealth Monitoring and Diagnostic Medical Devices Market: Market Segmentation
FIG. 2 Global mHealth Monitoring and Diagnostic Medical Devices Market, by Product Type, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global mHealth Monitoring and Diagnostic Medical Devices Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Porter’s Five Force Analysis: Global mHealth Monitoring and Diagnostic Medical Devices Market
FIG. 5 Market Attractiveness Analysis: Global mHealth Monitoring and Diagnostic Medical Devices Market, by Geography
FIG. 6 Evolution of Glucose Monitors
FIG. 7 Global Glucose Monitors Market, 2011 – 2019 (USD Million)
FIG. 8 Evolution in Blood Pressure Monitors Market
FIG. 9 Global Blood Pressure Monitors Market, 2011 – 2019 (USD Million)
FIG. 10 Evolution in Pulse Oximeters Market
FIG. 11 Global Pulse Oximeters Market, 2011 – 2019 (USD Million)
FIG. 12 Evolution in Cardiac Monitors Market
FIG. 13 Global Cardiac Monitors Market, 2011 – 2019 (USD Million)
FIG. 14 Global Sleep Apnea Monitors Market, 2011 – 2019 (USD Million)
FIG. 15 Evolution in Multi-parameter Monitors (Wearable Devices) Market
FIG. 16 Global Multi-parameter Monitors Market, 2011 – 2019 (USD Million)
FIG. 17 Global Other Monitors Market, 2011 – 2019 (USD Million)
FIG. 18 North America mHealth Monitoring and Diagnostic Medical Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Europe mHealth Monitoring and Diagnostic Medical Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Asia-Pacific mHealth Monitoring and Diagnostic Medical Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 RoW mHealth Monitoring and Diagnostic Medical Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Heat Map Analysis of Key Market Players of the mHealth Monitoring and Diagnostic Medical Devices Market
FIG. 23 Bayer HealthCare AG: Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 BioTelemetry, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 Boston Scientific Corporation: Annual Revenue, 2010–2012 (USD Million)
FIG. 26 DexCom, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Dräger AG: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 29 Johnson & Johnson: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 LifeWatch AG: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 Masimo Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 32 Medisana AG.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 33 Medtronic, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 34 Omron Healthcare, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

 

List of Tables

TABLE 1 Market Snapshot: Global mHealth Monitoring and Diagnostic Medical Devices Market (2012 & 2019)
TABLE 2 Global mHealth Diagnostic and Medical Devices Market Revenue, by Product Type, 2012 – 2019 (USD Million)
TABLE 3 Global mHealth Monitoring and Diagnostic Medical Devices Market Revenue, by Geography, 2011 – 2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


mHealthis an abbreviation for mobile health, a term used for the delivery of healthcare services with the use of communication devices, such as mobile phones, tablet computers and PDAs, for health services and information. mHealth monitoring and diagnostic medical devices is an emerging market and demand for this technology is evolving at a rapid speed owing to rising incidences of chronic diseases and increasing geriatric population. The technology substantially reduces healthcare expenditure incurred during hospital visits for monitoring vital parameters such as blood pressure, blood glucose, heart rate, respiratory rate and others. According to The Center for Technology and Aging, the U.S. healthcare system could reduce the cost of healthcare expenditure by approximately USD 200 billion in the next 25 years through the implementation of remote patient monitoring technologies. Hence, this report is focused towards identifying the current scenario as well as the future market potential for mHealth monitoring and diagnostic devices, globally, with a special focus on medical devices like smartphones and tablets. The mHealth monitoring and diagnostic devices market has been segmented into seven major product types, namely, glucose monitors, blood pressure monitors, pulse oximeters, cardiac monitors, sleep apnea monitors, multi-parameter monitoring devices and other monitoring devices (fetal monitors, neurological monitors, asthma monitoring devices). These monitors are used for monitoring and diagnosing health and wellness of a patient via connectivity with the smartphones or tablets that enable data transfer to healthcare professionals via Bluetooth, NFC, Wi-Fi or USB stick.

Of all the above mentioned monitoring and diagnostic devices, glucose monitors have been anticipated as the fastest growing segment for the forecast period 2013 to 2019, at a CAGR of 49.4%. According to the International Diabetes Federation (IDF), the number of people suffering globally from diabetes is around 392 million in 2013 and is expected to rise to 592 million by 2035. Hence, fastest growth rate of this segment is identified on the basis of year-on-year growth of diabetic patients globally and rising demand for invasive and minimally invasive glucose monitoring devices. In addition, global increase in number of smartphones and turnaround innovations in the mobile health devices, owing to improved technology are other important drivers of this market. Multi-parameter monitoring devices are also expected to witness significant growth rate in near future due to increasing awareness about health and fitness in developed countries.

Geographically, the mHealth monitoring and diagnostic medical devices market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). Presently, the North American region is the largest market in the world, owing to presence of large number of manufacturers, technological advancements, increasing population with smartphones and tablet PCs and growing awareness about the devices and technology. However, Asia-Pacific region is considered as the most promising markets during the forecast period 2013 to 2019. The growth is expected owing to factors such as higher incidence rate of chronic diseases, aging population, increased awareness about the diagnostic devices and rising demand for home-care monitoring systems. Rapid increase in smartphone users in countries such as India, Singapore, Australia, China, Japan and New Zealand is also propelling the growth of mHealth devices and application providers in these regions to equip themselves with advanced monitoring devices, connectible to smartphone and tablet PCs.

The market for mHealth monitoring and diagnostic medical devices is highly fragmented and each segment of the market is dominated by selected number of players. For instance, the market for glucose monitors is dominated by Sanofi LLC, iHealth Labs, Inc. and Medisana AG. The market for blood pressure monitors is dominated by iHealth Labs, Qardio and Withings, Inc. Masimo Corporation and Nonin Medical, Inc. are the prominent players in pulse oximeter market, whereas, cardiac monitors market is controlled by market leaders, such as, AliverCor Inc. and iMonSys Ltd. Sleep Apnea monitors market is dominated by Lark Technologies and Omron Healthcare. Finally, multi-parameter wearable monitoring devices market is controlled by FitBit, Inc., JawBone, and others. Additionally, more and more companies are entering the market, considering the growth perspective of the same.

global-mhealth-monitoring-and-diagnostic-medical-devices-market-revenue-by-product-type-2012

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research